Browse studies

Find your next paid study

6 recruiting studies matching your filters

A Double Blind Placebo-controlled Trial of StrataMGT for the Management of Vulvar Lichen Sclerosus Symptoms.

This study is designed to evaluate the efficacy and safety of StrataMGT for the management of vulvar lichen sclerosus symptoms.

Vulvar Lichen Sclerosus

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Andrew T. Goldstein, MDNCT06662942

Comprehensive Registry and PCR Analysis of the Vaginal Microbiome in Women: Data Collection in Healthy and Diseased States

The central premise of this study is that the intricate balance and diversity of the vaginal microbiome plays a pivotal role in the onset, progression, and sev…

Bacterial VaginosisCandidiasisUrinary Tract Infections+8 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Vaginal Biome ScienceNCT06472765

Phase 2

Nemolizumab for the Treatment of Lichen Sclerosus

Patients ≥ 18 years of age with Lichen sclerosis (LS)

Lichen Sclerosus of Vulva

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of Texas Southwestern Medical CenterNCT07704775

Observational

VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Vulvovaginal skin conditions, namely vaginal atrophy, lichen sclerosus, lichen simplex chronicus and lichen planus affecting the female adult population will b…

Atrophic VaginitisVaginal AtrophyGenitourinary Syndrome of Menopause+3 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Stratpharma AGNCT05953090

Phase 2

Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial

We are looking to see if patients using both topical testosterone and estrogen will have a greater improvement in pain with vaginal penetration compared to tho…

VulvodyniaDyspareuniaLichen Sclerosus of Vulva

Estimated

~$75 – $2,800

Actual pay is set by the research site.

TriHealth Inc.NCT07260825

Phase 3

A Phase 3, Double-blinded, Vehicle-controlled Trial to Investigate the Efficacy and Safety of Twice Daily Delgocitinib Cream in Adult Participants With Lichen Sclerosus During a 12-Week Initial Treatment Period Followed by a 40-Week Continuation Treatment Period

The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of a…

Lichen Sclerosus

Estimated

~$50 – $2,100

Actual pay is set by the research site.

LEO PharmaNCT07335588